The present work provides an evidence for a positive ROR/Nanog correlation and the crosstalk between miR-145, ROR and Nanog, shedding new light on the potential therapeutic target in pancreatic cancer. This evidence concerns the gene LINC-ROR and familial pancreatic carcinoma.